Clinical trial Recruiting at 1 site Interventional Ages 12 to 18

Effect of high-definition brain stimulation on non-suicidal self-injury

Official title: Intervention Effect of High-Definition Transcranial Alternating Current Stimulation (HD-tACS) on Non-suicidal Self-injury (NSSI)

Run by Anhui Medical University · NCT06127056 · Data updated 2026-11-12

This study is testing if a special type of brain stimulation can help teenagers who hurt themselves without wanting to die feel better and understand their behavior better.

More Transcranial Alternating Current Stimulation trials

Quick facts

Study typeInterventional
Ages12 Years to 18 Years
SexAll
Enrollment40 (estimated)
SponsorAnhui Medical University
Academic / other
Locations1 site (Hefei, Anhui)
StatusRecruiting
StartedMay 1, 2023
Main results expectedAugust 30, 2026
Study endsAugust 30, 2026
Registry record updatedJuly 22, 2026
Trial IDNCT06127056 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adolescents aged 12-18 diagnosed with non-suicidal self-injury who have not changed their medication in the past month.

Probably not a fit

Patients with suicidal ideation, neurological disorders, or a history of substance abuse may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of high-definition transcranial alternating current stimulation (HD-tACS) on patients aged 12-18 who engage in non-suicidal self-injury (NSSI). Forty participants diagnosed with NSSI will receive either active or sham HD-tACS treatment over a week, with assessments conducted before and after the intervention. The study aims to explore the underlying neural mechanisms of NSSI using magnetic resonance imaging (MRI) alongside neuropsychological evaluations. Participants will be randomized to ensure the reliability of results.

Why it matters

Potential benefit: If successful, this intervention could provide a novel non-invasive treatment option for adolescents struggling with non-suicidal self-injury.

How similar studies have gone: While the use of HD-tACS is a relatively novel approach, preliminary studies in related areas suggest potential benefits, though this specific application is less explored.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

The patients were diagnosed by 2 or more senior clinical psychiatrists, meeting DSM-V criteria, and having 1 or more non-suicidal self-injurious behaviors in the last 6 months.

12-18 years of age.

The medicine has not changed in the 4 weeks prior to or after this study, and if it has to be changed, the treatment medication is required to be at a subtherapeutic dosage level.

Exclusion Criteria:

The patient has suicidal ideation or has committed suicidal behavior

T1 or T2 weighted phase magnetic resonance images show focal brain lesions

patients had neurological disorders such as epilepsy, or serious physical illnesses

patients had a history of substance abuse and drug dependence in the last 6 months or use of anticonvulsant drugs in the last 3 months

patients had received radial cranial electrical stimulation or magnetic stimulation treatment in the last 3 months or received electroconvulsive therapy in the last 6 months

patients had previous significant head trauma or EEG abnormality in the last 1 month

body-mounted devices unsuitable for treatment, such as pacemakers, artificial valves, and other metal implants.

Where it's running

  • Anhui Medical University
    Hefei, Anhui, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.